⚖️ Weight Management · Apgujeong Hana Clinic
Saxenda Weight Loss Seoul
English-friendly Saxenda and liraglutide consultation with a board-certified endocrinologist in Gangnam—covering eligibility, daily pen training, gradual dose escalation, side-effect management and long-term weight-maintenance planning.
✓
Liraglutide eligibility review
✓
Once-daily pen guidance
✓
English follow-up
Liraglutide Daily GLP-1 Map
A daily medicine supporting appetite regulation and weight management
Once daily
24h
Liraglutide
Injection
Injection
Fullness & Food Intake
Treatment may increase fullness and help reduce energy intake when combined with nutrition and physical activity.
HUNGER
Daily appetite pattern
FULLNESS
Meal satisfaction
INTAKE
Portion awareness
FOLLOW-UP
Dose and tolerance
Saxenda is the liraglutide brand developed for chronic weight management. It is not the same treatment pathway as once-weekly semaglutide or tirzepatide medicines, and it should not be combined with another liraglutide product or GLP-1 receptor agonist.
🩺
Prescription Assessment
Treatment begins after an individual weight, metabolic and safety review.
💉
Daily Liraglutide
Saxenda is injected under the skin once each day using a multidose pen.
📈
Five-Step Escalation
The dose generally rises weekly from 0.6 mg toward 3 mg daily.
🔄
Response Monitoring
Weight, appetite, side effects, heart rate and metabolic health are reviewed.
✓
Board-Certified Endocrinologist
✓
Saxenda Prescription Assessment
✓
English Pen Training
✓
Apgujeong · Gangnam
Understanding Liraglutide
Saxenda contains liraglutide, a GLP-1 receptor agonist for weight management.
Saxenda is a prescription injectable medicine used with a reduced-calorie eating plan and increased physical activity to reduce excess body weight and support long-term weight maintenance in eligible patients.
Liraglutide is similar to the natural GLP-1 hormone involved in appetite regulation. It may help patients feel fuller, experience less hunger and reduce food intake. Saxenda is taken every day rather than once weekly.
At Apgujeong Hana Clinic, Dr. Shin Hyun-won reviews BMI, weight history, metabolic conditions, current medicines and contraindications before deciding whether Saxenda or another treatment is more suitable.
🧬
GLP-1 Receptor Activity
Liraglutide works through the GLP-1 pathway involved in appetite and food intake.
📅
Once-Daily Injection
The prefilled pen is used every day, with injection sites rotated.
⚖️
Weight-Management Indication
Saxenda is specifically developed for chronic weight management where authorised.
🥗
Combined Treatment Plan
Medication is paired with nutrition, movement and follow-up rather than used alone.
Saxenda, Victoza & Liraglutide
The active ingredient is the same, but the approved purpose and target dose are different.
⚖️
Saxenda
Saxenda contains liraglutide and follows a chronic weight-management indication. The usual adult target dose is 3 mg once daily after gradual escalation, when tolerated and prescribed.
2️⃣
Victoza
Victoza also contains liraglutide but is used for Type 2 diabetes under a different indication and lower labelled dose range. The pens and treatment plans should not be treated as interchangeable.
Do not use Saxenda together with Victoza or another GLP-1 medicine
Combining liraglutide-containing products or adding another GLP-1 receptor agonist is not recommended. The endocrinologist reviews all injections and diabetes medicines before prescribing.
Who May Be Considered?
Eligibility depends on BMI, weight-related health risks and individual medical safety.
Adults With Obesity
Saxenda may be considered when BMI meets the relevant obesity threshold and medical criteria.
Overweight With Comorbidity
High blood pressure, abnormal cholesterol, sleep apnoea, prediabetes or Type 2 diabetes may affect eligibility.
Repeated Weight Regain
Medication may be discussed when structured lifestyle attempts have not produced sustainable results.
Metabolic Risk
Glucose, blood pressure, fatty liver and lipid findings help shape the overall treatment plan.
Daily Treatment Routine
Patients need to be able to follow a daily injection, storage and pen-use routine consistently.
International Patients
Eligibility review, injection education and follow-up explanations are available in English.
Before Starting Saxenda
The first consultation evaluates benefit, risk and alternative treatment options.
🩺
Saxenda should not be selected from body weight alone.
The assessment considers weight history, metabolic disease, current medicines, digestive health, pregnancy plans, mental health and whether a daily injection fits your treatment needs.
📋
Weight & BMI History
Previous programs, injections, weight regain and current goals are reviewed.
🩸
Glucose & Diabetes Medicines
Insulin or sulfonylureas may require closer glucose monitoring and dose review.
🧬
Thyroid Cancer History
Personal or family history of medullary thyroid carcinoma or MEN2 must be disclosed.
🥣
Pancreas & Gallbladder
Pancreatitis, gallstones, gallbladder symptoms and severe digestive disease are discussed.
❤️
Heart Rate & Kidney Health
Resting pulse, dehydration risk and kidney problems may require additional monitoring.
🤰
Pregnancy & Mental Health
Pregnancy plans, breastfeeding, depression and suicidal thoughts require specific discussion.
How Saxenda Supports Weight Management
Daily liraglutide supports appetite regulation while lifestyle care supports long-term results.
Reduced Hunger
Some patients experience less frequent hunger or fewer appetite-driven eating episodes.
Earlier Fullness
Feeling satisfied with a smaller meal may help reduce overall energy intake.
Craving Awareness
Reduced appetite intensity may make structured meal planning easier to follow.
Digestive Effects
Liraglutide delays gastric emptying and can also cause gastrointestinal side effects.
Muscle-Preserving Plan
Protein intake and resistance exercise remain important during weight reduction.
Maintenance Strategy
Follow-up addresses response, plateaus, treatment duration and possible weight regain.
Saxenda Dose Escalation
Saxenda normally increases in five weekly steps toward 3 mg once daily.
This is the standard labelled adult escalation sequence, not a personal prescription. The doctor may delay an increase when side effects remain significant.
0.6 mg
Week 1
Starting dose used to introduce daily treatment and assess early tolerance.
1.2 mg
Week 2
First escalation step when the starting dose is tolerated.
1.8 mg
Week 3
Intermediate daily dose during gradual titration.
2.4 mg
Week 4
Final titration step before the usual adult treatment dose.
3 mg
Week 5+
Recommended adult daily dose when tolerated and clinically appropriate.
Do not increase the dose faster or double a missed dose
If more than three days have passed since the last injection, current prescribing information advises restarting at 0.6 mg and repeating escalation to reduce gastrointestinal reactions. Contact the clinic for individual instructions.
Common Side Effects
Digestive symptoms are most common during initiation and dose escalation.
Nausea
Smaller meals, avoiding overeating and slower escalation may improve tolerance.
Diarrhea
Loose or frequent stool may occur, especially during early treatment.
Constipation
Lower food intake, dehydration and slower digestion may contribute.
Vomiting
Repeated vomiting can cause dehydration and requires treatment review.
Abdominal Symptoms
Pain, indigestion, bloating or upper-abdominal discomfort may occur.
Other Common Effects
Headache, fatigue, dizziness or injection-site reactions can occur.
Important Safety Information
Some medical histories require avoidance, treatment changes or closer monitoring.
📋 Tell The Doctor Before Treatment
✓
All prescriptions, supplements and other weight-loss or diabetes injections.
✓
Insulin or sulfonylurea use because low blood sugar risk may increase.
✓
Previous pancreatitis, gallstones, gallbladder disease or severe abdominal symptoms.
✓
Kidney disease, dehydration, severe gastroparesis or recurrent vomiting.
✓
Depression, suicidal thoughts, planned surgery, endoscopy or deep sedation.
⚠️ Saxenda May Not Be Appropriate
!
With personal or family history of medullary thyroid carcinoma.
!
With Multiple Endocrine Neoplasia syndrome type 2.
!
With a serious allergy to liraglutide or Saxenda ingredients.
!
During pregnancy; treatment should be stopped when pregnancy is recognised.
!
Together with Victoza, another liraglutide product or another GLP-1 medicine.
Tell your surgery or endoscopy team that you use Saxenda
GLP-1 medicines delay stomach emptying, and pulmonary aspiration has been reported during general anaesthesia or deep sedation. Your medical team must provide individual fasting and medication instructions.
Seek Prompt Medical Advice
Severe, persistent or unusual symptoms need clinical assessment.
🤕
Severe Abdominal Pain
Persistent pain, especially when spreading to the back or occurring with vomiting, may require urgent pancreatitis evaluation.
🟡
Gallbladder Symptoms
Upper-right abdominal pain, fever, jaundice or pale stool may indicate gallstones or gallbladder inflammation.
💧
Dehydration
Very low urine output, faintness, confusion or inability to keep fluids down requires prompt review.
🩸
Low Blood Sugar
Sweating, shaking, confusion or weakness is especially important with insulin or sulfonylureas.
🚨
Allergic Reaction
Facial swelling, breathing difficulty or widespread rash requires emergency medical care.
🧠
Mood Or Thyroid Symptoms
New suicidal thoughts, a neck lump, persistent hoarseness or difficulty swallowing should be reported promptly.
More Than A Daily Injection
Saxenda works within a complete medical weight-management plan.
Nutrition Strategy
Balanced portions, adequate protein, fibre and hydration support tolerance and muscle health.
Strength Preservation
Resistance activity helps protect muscle and physical function during weight loss.
Regular Movement
Walking and aerobic activity are progressed according to fitness and medical conditions.
Sleep & Recovery
Sleep quality and possible sleep apnoea may affect appetite, energy and metabolic health.
Health Monitoring
Weight, waist, blood pressure, glucose, lipids and resting heart rate may be followed.
Response Checkpoint
The doctor assesses whether treatment is producing enough benefit to justify continuation.
Your Saxenda Clinic Visit
How consultation, prescription, pen training and monitoring work.
1
Book In English
Contact the clinic and mention that you need a Saxenda or liraglutide weight-management consultation.
2
Medical Assessment
Review BMI, weight history, metabolic health, medicines, contraindications and treatment goals.
3
Prescription & Pen Training
When appropriate and available, receive dose, storage, needle, injection-site and missed-dose guidance.
4
Escalation & Follow-Up
Review appetite, weight, side effects, daily adherence and whether to continue or change treatment.
Apgujeong, Gangnam
Saxenda and liraglutide consultation in English.
Apgujeong Hana Clinic provides specialist-led obesity and metabolic care for expats, residents and international patients in Seoul.
📍
328 Apgujeong-ro, Gangnam-gu, Seoul, KFC Building 3F
🕘
Monday–Friday 09:00–19:00
🗓️
Saturday 09:00–13:00
📞
02) 3443-7550
⚕️
Dr. Shin Hyun-won
Board-certified endocrinologist and internal-medicine specialist with more than 20 years of experience in diabetes, hormones, obesity and metabolic medicine.
FAQ
Saxenda weight-loss questions, answered.
Prescription, local indication and availability are confirmed during consultation. Do not change your dose without medical guidance.
Apgujeong Hana Clinic offers medical assessment for Saxenda and other prescription weight-management treatments. Prescription depends on eligibility, safety, Korean requirements and current product availability.
No. Saxenda contains liraglutide and is injected daily. Ozempic and Wegovy contain semaglutide and are generally injected weekly. Their indications, doses, pens and treatment plans differ.
Saxenda is injected under the skin once daily in the abdomen, thigh or upper arm. Rotate injection sites and follow the pen instructions provided by the clinic.
The standard adult escalation is 0.6 mg daily for week 1, then 1.2 mg, 1.8 mg, 2.4 mg and 3 mg in weekly steps. The dose may be delayed or treatment changed if side effects are not tolerated.
Do not double the next dose. Resume the next scheduled daily dose. When more than three days have passed, contact the clinic because restarting at 0.6 mg and repeating escalation may be required.
Results vary. Response depends on starting weight, adherence, dose tolerance, nutrition, activity and medical factors. The doctor uses a formal response checkpoint to decide whether continued treatment is worthwhile.
Nausea, diarrhea, constipation and vomiting are common. Abdominal discomfort, headache, fatigue, dizziness and injection-site reactions can also occur, particularly during escalation.
Saxenda is contraindicated with personal or family history of medullary thyroid carcinoma, MEN2 or serious hypersensitivity to liraglutide. Pregnancy, severe gastrointestinal disease and other risks require medical review.
No. Saxenda should not be coadministered with another liraglutide-containing product or another GLP-1 receptor agonist unless a specialist has specifically replaced one treatment with another.
Tell the anaesthesia, surgery or endoscopy team that you use Saxenda. Because it delays stomach emptying, they must provide individual instructions about fasting and whether the medicine should be held.
Related Weight Treatments
Compare other medically supervised options.
Start With A Medical Assessment
Book your Saxenda consultation in Gangnam.
Discuss eligibility, daily pen use, dose escalation, side effects and alternatives with an English-speaking endocrinology clinic in Seoul.